Method of determining specific groups forming heparins

Details for Australian Patent Application No. 2003279430 (hide)

Owner Aventis Pharma S.A.

Inventors Viskov, Christian; Mourier, Pierre

Agent Watermark

Pub. Number AU-B-2003279430

PCT Number PCT/FR03/02782

PCT Pub. Number WO2004/027087

Priority 02/11724 23.09.02 FR; 60/422,482 31.10.02 US

Filing date 22 September 2003

Wipo publication date 8 April 2004

Acceptance publication date 11 September 2008

International Classifications

C12Q 1/527 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving lyase

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 02/11724 23.09.02 FR; 60/422,482 31.10.02 US

20 May 2004 Application Open to Public Inspection

  Published as AU-B-2003279430

11 September 2008 Application Accepted

  Published as AU-B-2003279430

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003279431-METHOD AND DEVICE FOR REDUCING PRODUCTION OF WASTEWATER TREATMENT STATION SLUDGE WITH FIXED BIOLOGICAL CULTURES

2003279429-DIASTEREOSELECTIVE METHOD OF PREPARING OLEFINS BY MEANS OF THE HORNERWADSWORTH-EMMONS REACTION, COMPRISING THE ADDITION OF A TRIS-(POLYOXAALKYL)-AMINE SEQUESTERING AGENT